[1]
2026. DETERMINATION OF TUMOUR MARKER PSA AND RFTs IN PROSTATIC CANCER PATIENTS. Review Journal of Neurological & Medical Sciences Review. 4, 5 (May 2026), 223–231. DOI:https://doi.org/10.63075/95pc9k34.